BlackRock, Inc. filed Amendment No. 17 to its Schedule 13G with the SEC on October 27, 2026, disclosing its beneficial ownership position in Clorox common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: BlackRock reported beneficial ownership of 7,665,771 shares of Clorox common stock, representing 6.3% of the class.
  • Sole voting power: BlackRock disclosed sole power to vote or direct the vote of 7,279,139 shares.
  • Sole dispositive power: BlackRock reported sole power to dispose of or direct the disposition of 7,665,771 shares.
  • Shared voting and dispositive power: Both shared voting power and shared dispositive power were reported as 0 shares.
  • Filing event date: The date of the event requiring this filing was reported as September 30, 2026.
  • Signatory: The filing was signed by Spencer Fleming, Managing Director of BlackRock, Inc., on October 27, 2026.

BlackRock's Disclosed Clorox Holdings as of September 30, 2026

BlackRock, Inc., organized in Delaware and headquartered at 50 Hudson Yards, New York, NY 10001, filed Amendment No. 17 to Schedule 13G regarding its holdings in Clorox (CUSIP 189054109), whose principal executive offices are located at 1221 Broadway, Oakland, CA 94612-1888. According to the filing, BlackRock reported aggregate beneficial ownership of 7,665,771 shares of Clorox common stock, representing 6.3% of the outstanding class as of the September 30, 2026 event date.

The filing disclosed that BlackRock holds sole voting power over 7,279,139 shares and sole dispositive power over the full 7,665,771 shares. Shared voting power and shared dispositive power were each reported as 0. The filing noted that, in accordance with SEC Release No. 34-39538 (January 12, 1998), the Schedule 13G "reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the 'Reporting Business Units') of BlackRock, Inc. and its subsidiaries and affiliates," and does not include securities beneficially owned by other business units whose beneficial ownership is disaggregated from that of the Reporting Business Units.

Regarding dividends or sale proceeds, the filing stated that "various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of CLOROX," and that "no one person's interest in the common stock of CLOROX is more than five percent of the total outstanding common shares." BlackRock certified that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of changing or influencing control of Clorox.

What Was Disclosed

BlackRock, Inc. disclosed beneficial ownership of 7,665,771 Clorox common shares, equal to 6.3% of the class, with sole voting power over 7,279,139 shares and sole dispositive power over all 7,665,771 shares, as of September 30, 2026.